Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-006957

Options or other derivatives

  • See Remarks acquired 53,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ho Tony W See Remarks 2018-03-07 Grant or award · Stock Option (Right to Buy) +53,000 53,000 D
Loading xslF345X03/doc4.xml…